TTC24
gene geneOn this page
Summary
TTC24 (tetratricopeptide repeat domain 24, HGNC:32348) is a protein-coding gene on chromosome 1q22, encoding Tetratricopeptide repeat protein 24 (A2A3L6).
At a glance
- Clinical variants (ClinVar): 92 total
- MANE Select transcript:
NM_001105669
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32348 |
| Approved symbol | TTC24 |
| Name | tetratricopeptide repeat domain 24 |
| Location | 1q22 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000187862 |
| Ensembl biotype | protein_coding |
| Entrez | 164118 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 3 retained_intron, 1 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000368236, ENST00000413282, ENST00000462049, ENST00000478081, ENST00000495690
RefSeq mRNA: 1 — MANE Select: NM_001105669
NM_001105669
CCDS: CCDS53379
Canonical transcript exons
ENST00000368236 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001446662 | 156586469 | 156587719 |
| ENSE00002246691 | 156579723 | 156579758 |
| ENSE00002298601 | 156581361 | 156582070 |
| ENSE00002304117 | 156585949 | 156586045 |
| ENSE00002312153 | 156585125 | 156585231 |
| ENSE00003481568 | 156583338 | 156583450 |
| ENSE00003525724 | 156583797 | 156583895 |
| ENSE00003604126 | 156584877 | 156584974 |
| ENSE00003642703 | 156585713 | 156585826 |
| ENSE00003706306 | 156582231 | 156582434 |
| ENSE00003707652 | 156583042 | 156583170 |
Expression profiles
Bgee: expression breadth ubiquitous, 107 present calls, max score 79.10.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3462 / max 36.6681, expressed in 83 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 5732 | 0.3379 | 81 |
| 201756 | 0.0083 | 2 |
Top tissues by expression
117 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 79.10 | gold quality |
| lymph node | UBERON:0000029 | 78.56 | gold quality |
| spleen | UBERON:0002106 | 74.18 | gold quality |
| vermiform appendix | UBERON:0001154 | 73.57 | gold quality |
| blood | UBERON:0000178 | 65.71 | gold quality |
| bone marrow | UBERON:0002371 | 65.31 | gold quality |
| tonsil | UBERON:0002372 | 64.23 | gold quality |
| leukocyte | CL:0000738 | 63.45 | gold quality |
| monocyte | CL:0000576 | 62.95 | gold quality |
| bone marrow cell | CL:0002092 | 60.16 | silver quality |
| small intestine Peyer’s patch | UBERON:0003454 | 57.39 | gold quality |
| pituitary gland | UBERON:0000007 | 56.71 | gold quality |
| adenohypophysis | UBERON:0002196 | 56.39 | gold quality |
| small intestine | UBERON:0002108 | 55.75 | gold quality |
| primary visual cortex | UBERON:0002436 | 55.38 | gold quality |
| gastrocnemius | UBERON:0001388 | 54.18 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 53.99 | gold quality |
| muscle of leg | UBERON:0001383 | 53.59 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 53.17 | gold quality |
| gall bladder | UBERON:0002110 | 52.10 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 52.06 | gold quality |
| muscle tissue | UBERON:0002385 | 49.02 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 48.58 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 47.35 | silver quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 46.66 | gold quality |
| right coronary artery | UBERON:0001625 | 46.10 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 46.05 | gold quality |
| frontal cortex | UBERON:0001870 | 45.95 | gold quality |
| right frontal lobe | UBERON:0002810 | 45.83 | gold quality |
| body of stomach | UBERON:0001161 | 45.79 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.73 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
7 targeting TTC24, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4721 | 99.26 | 66.05 | 818 |
| HSA-MIR-6814-5P | 99.03 | 66.68 | 1273 |
| HSA-MIR-605-5P | 98.79 | 68.24 | 1161 |
| HSA-MIR-4520-3P | 98.75 | 66.55 | 963 |
| HSA-MIR-647 | 97.73 | 67.79 | 927 |
| HSA-MIR-12128 | 96.67 | 66.98 | 1471 |
| HSA-MIR-764 | 94.16 | 64.85 | 656 |
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| rattus_norvegicus | Ttc24 | ENSRNOG00000028765 |
Paralogs (6): TTC28 (ENSG00000100154), GPSM2 (ENSG00000121957), TTC29 (ENSG00000137473), GPSM1 (ENSG00000160360), RAPSN (ENSG00000165917), GPSM3 (ENSG00000213654)
Protein
Protein identifiers
Tetratricopeptide repeat protein 24 — A2A3L6 (reviewed: A2A3L6)
All UniProt accessions (1): A2A3L6
RefSeq proteins (1): NP_001099139* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR011990 | TPR-like_helical_dom_sf | Homologous_superfamily |
| IPR019734 | TPR_rpt | Repeat |
| IPR024812 | TPR_24 | Family |
Pfam: PF13176, PF13424
UniProt features (17 total): repeat 8, region of interest 3, sequence variant 3, compositionally biased region 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A2A3L6-F1 | 73.99 | 0.56 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 19 (showing top):
chr1q22, MARSON_BOUND_BY_FOXP3_STIMULATED, MARSON_BOUND_BY_E2F4_UNSTIMULATED, GSE13522_WT_VS_IFNG_KO_SKIN_DN, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, NFKBIA_TARGET_GENES, NKX2_3_TARGET_GENES, SFMBT1_TARGET_GENES, SIX1_TARGET_GENES, ZNF528_TARGET_GENES, MIR6814_5P, GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_DN, DESCARTES_FETAL_PANCREAS_LYMPHOID_CELLS, ZNF134_TARGET_GENES, HOEK_NK_CELL_2011_2012_TIV_1D_VS_0DY_ADULT_1D_DN
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
978 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TTC24 | GON4L | Q3T8J9 | 567 |
| TTC24 | IQGAP3 | Q86VI3 | 440 |
| TTC24 | NANS | Q9NR45 | 438 |
| TTC24 | ITPRIPL2 | Q3MIP1 | 403 |
| TTC24 | CYTH2 | Q99418 | 393 |
| TTC24 | SPTA1 | P02549 | 373 |
| TTC24 | ASH1L | Q9NR48 | 359 |
| TTC24 | BCAN | Q96GW7 | 325 |
| TTC24 | PPP1R16A | Q96I34 | 318 |
| TTC24 | MEF2D | Q14814 | 283 |
| TTC24 | IFT38 | Q96AJ1 | 283 |
| TTC24 | COG2 | Q14746 | 250 |
| TTC24 | KIFAP3 | Q92845 | 222 |
| TTC24 | MYL6B | P14649 | 210 |
| TTC24 | IST1 | P53990 | 206 |
IntAct
82 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TTC24 | LNX2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | RADIL | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | PDZD7 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | MAST2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | DLG1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | HTRA1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | DLG4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | DLG3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | DLG2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | RHPN1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | ARHGEF11 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | HTRA4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | APBA1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | MAST1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | GORASP1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | PDZD2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| LNX1 | TTC24 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | PATJ | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | TAMALIN | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | GORASP2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | SNX27 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | MAGI2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | SNTA1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | SNTB1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | MAGI3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | ARHGEF12 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TTC24 | GOPC | psi-mi:“MI:0407”(direct interaction) | 0.440 |
BioGRID (1): NUP98 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A1L3T7, A2A3L6, A4IFI1, A7E3N7, A8MYJ7, A8VU90, O94761, O94812, O95153, O95382, P97680, Q0P5G1, Q13671, Q14154, Q3UYR4, Q4V896, Q53GL7, Q569K6, Q58CQ5, Q58EX7, Q66H85, Q6DT37, Q6F5E8, Q6ZVH7, Q76MJ5, Q7TNF8, Q7Z3H0, Q80UU1, Q80UW5, Q8BWA8, Q8BXP5, Q8BYG0, Q8CIE4, Q8CJ00, Q8IYJ3, Q8NAG6, Q8TE82, Q91WA6, Q91WE1, Q921Q7
Diamond homologs: A2A3L6, Q8BYG0
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 65 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Ras activation upon Ca2+ influx through NMDA receptor | 5 | 66.4× | 4e-07 |
| Unblocking of NMDA receptors, glutamate binding and activation | 5 | 63.2× | 4e-07 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | 5 | 63.2× | 4e-07 |
| Long-term potentiation | 5 | 55.3× | 7e-07 |
| Assembly and cell surface presentation of NMDA receptors | 8 | 47.2× | 7e-10 |
| Neurexins and neuroligins | 8 | 36.6× | 3e-09 |
| Protein-protein interactions at synapses | 5 | 30.9× | 1e-05 |
| RHOA GTPase cycle | 5 | 8.7× | 2e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| establishment or maintenance of epithelial cell apical/basal polarity | 11 | 101.5× | 1e-17 |
| protein localization to synapse | 6 | 73.0× | 2e-08 |
| receptor clustering | 7 | 69.3× | 1e-09 |
| regulation of postsynaptic membrane neurotransmitter receptor levels | 7 | 55.1× | 5e-09 |
| regulation of small GTPase mediated signal transduction | 5 | 11.4× | 3e-03 |
| cell-cell adhesion | 7 | 11.3× | 2e-04 |
| protein-containing complex assembly | 6 | 10.8× | 7e-04 |
| chemical synaptic transmission | 6 | 7.4× | 4e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
92 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 81 |
| Likely benign | 6 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1628 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:156579759:GTAAG:G | donor_loss | 1.0000 |
| 1:156582395:G:GT | donor_gain | 1.0000 |
| 1:156582403:G:GT | donor_gain | 1.0000 |
| 1:156583169:TGG:T | donor_loss | 1.0000 |
| 1:156583171:G:GG | donor_gain | 1.0000 |
| 1:156583171:GTA:G | donor_loss | 1.0000 |
| 1:156583172:T:G | donor_loss | 1.0000 |
| 1:156583795:A:AG | acceptor_gain | 1.0000 |
| 1:156583796:G:GG | acceptor_gain | 1.0000 |
| 1:156584947:G:GT | donor_gain | 1.0000 |
| 1:156585228:GAGC:G | donor_gain | 1.0000 |
| 1:156585230:GC:G | donor_gain | 1.0000 |
| 1:156579755:GGAG:G | donor_gain | 0.9900 |
| 1:156579756:GAG:G | donor_gain | 0.9900 |
| 1:156579756:GAGG:G | donor_gain | 0.9900 |
| 1:156579759:G:GG | donor_gain | 0.9900 |
| 1:156579760:T:G | donor_loss | 0.9900 |
| 1:156581359:A:AG | acceptor_gain | 0.9900 |
| 1:156581360:G:GG | acceptor_gain | 0.9900 |
| 1:156581360:GCCCT:G | acceptor_gain | 0.9900 |
| 1:156581969:G:GT | donor_gain | 0.9900 |
| 1:156582089:G:T | donor_gain | 0.9900 |
| 1:156582226:TCTA:T | acceptor_loss | 0.9900 |
| 1:156582227:CTA:C | acceptor_loss | 0.9900 |
| 1:156582228:TAG:T | acceptor_loss | 0.9900 |
| 1:156582229:A:AC | acceptor_loss | 0.9900 |
| 1:156582433:CG:C | donor_gain | 0.9900 |
| 1:156582434:GG:G | donor_gain | 0.9900 |
| 1:156582435:G:GG | donor_gain | 0.9900 |
| 1:156582435:GT:G | donor_loss | 0.9900 |
AlphaMissense
3748 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:156583074:A:C | S315R | 0.988 |
| 1:156583076:C:A | S315R | 0.988 |
| 1:156583076:C:G | S315R | 0.988 |
| 1:156583376:G:T | G360W | 0.981 |
| 1:156583377:G:A | G360E | 0.977 |
| 1:156583433:G:C | A379P | 0.973 |
| 1:156582362:G:T | G280W | 0.972 |
| 1:156583376:G:A | G360R | 0.970 |
| 1:156583376:G:C | G360R | 0.970 |
| 1:156583146:G:C | A339P | 0.969 |
| 1:156583092:T:C | F321L | 0.965 |
| 1:156583094:T:A | F321L | 0.965 |
| 1:156583094:T:G | F321L | 0.965 |
| 1:156583125:G:C | A332P | 0.962 |
| 1:156583090:C:A | A320D | 0.959 |
| 1:156582363:G:A | G280E | 0.957 |
| 1:156582362:G:A | G280R | 0.956 |
| 1:156582362:G:C | G280R | 0.956 |
| 1:156583101:A:C | S324R | 0.956 |
| 1:156583103:C:A | S324R | 0.956 |
| 1:156583103:C:G | S324R | 0.956 |
| 1:156582419:G:C | A299P | 0.955 |
| 1:156583385:G:C | A363P | 0.955 |
| 1:156582308:G:C | A262P | 0.954 |
| 1:156582422:G:C | A300P | 0.952 |
| 1:156581725:T:C | F121L | 0.951 |
| 1:156581727:C:A | F121L | 0.951 |
| 1:156581727:C:G | F121L | 0.951 |
| 1:156582299:T:C | F259L | 0.951 |
| 1:156582301:C:A | F259L | 0.951 |
dbSNP variants (sampled 300 via entrez): RS1000108023 (1:156585585 C>T), RS1000164853 (1:156580836 A>G), RS1000661597 (1:156585496 C>T), RS1000977216 (1:156584025 G>C), RS1001109875 (1:156584293 G>C), RS1001893246 (1:156580528 A>G), RS1001915228 (1:156584759 C>T), RS1002496196 (1:156578806 C>T), RS1002530248 (1:156587287 G>A), RS1002648030 (1:156582410 C>T), RS1002700442 (1:156582616 T>G), RS1003435601 (1:156581303 C>T), RS1003592639 (1:156585952 C>T), RS1003953753 (1:156587439 G>A), RS1004006646 (1:156581996 G>A,C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Methapyrilene | increases methylation | 1 |
| Tobacco Smoke Pollution | decreases methylation | 1 |
| Vitamin E | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.